Moderna将继续在进行中的第二阶段临床试验中评估MRNA-1647在骨髓移植患者中的应用
Moderna将继续在进行中的第二阶段临床试验中评估MRNA-1647在骨髓移植患者中的应用
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.